Walgreens GLP-1 Cost: What You'll Pay With and Without Insurance
Walgreens GLP-1 cost breakdown: brand-name semaglutide and tirzepatide retail pricing, how copays and prior authorization work, and what discount cards actually do.
Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. We analyze GLP-1 pricing across retail pharmacies and telehealth providers to help patients find the best value.
Quick links: Semaglutide treatment, Trimi pricing, and cheapest GLP-1 injections 2026.
More on GLP-1 Provider Comparisons
Walgreens GLP-1 Pricing Overview
Understanding GLP-1 costs at Walgreens requires separating the brand-name retail reality from the marketing. Brand-name semaglutide (Wegovy) and tirzepatide (Zepbound) carry manufacturer-set prices that all retail pharmacies, including Walgreens, must work within. The resulting prices, $900 to $1,400+ per month without insurance, reflect the economics of patented brand-name pharmaceuticals, not Walgreens-specific pricing decisions.
For insured patients whose plans cover GLP-1 medications, Walgreens seamlessly processes claims and can be a convenient access point. Copays vary enormously depending on your specific plan, from as low as $25 to as high as $500 or more. Many plans require prior authorization, step therapy, or documented BMI thresholds before approving GLP-1 coverage.
For self-pay patients, and that includes the millions whose insurance does not cover GLP-1 medications or who have high deductibles, the first move is to work the manufacturer programs: Novo Nordisk's and Eli Lilly's direct self-pay channels, and their savings cards if you have commercial coverage. Separately, telehealth providers such as Trimi dispense compounded preparations on a flat cash-pay basis; those are not FDA-approved as drugs, and whether one is appropriate is a decision for a licensed clinician.
Retail Pharmacy vs Telehealth: How the Two Channels Work
| Factor | Walgreens (Brand-Name) | Trimi (Compounded) |
|---|---|---|
| Product type | FDA-approved finished drug | Compounded per prescription; not FDA-approved as a drug |
| Clinical evidence | Own clinical trial program | No trials of its own |
| Consultation | Separate provider required | Included |
| Shipping/Pickup | In-store pickup | Free overnight delivery once compounded |
| Dose format | Pre-filled pens | Vials with syringes |
| Insurance billing | Yes, if your plan covers it | No; cash-pay only |
| How you pay | Copay, or list price if self-pay | Flat rate, same at every dose |
Pricing Note
Walgreens prices reflect self-pay brand-name pricing. Insurance copays vary widely. Verify all pricing directly with your pharmacy and provider.
Why Brand-Name Pricing Is So High
Brand-name GLP-1 pricing is set by manufacturers, Novo Nordisk for Wegovy and Eli Lilly for Zepbound, at levels reflecting their patent protection, clinical development costs, and market demand. Retail pharmacies like Walgreens have limited ability to reduce these prices below the wholesale acquisition cost. The result is pricing that makes these medications inaccessible to most self-pay patients through the retail pharmacy channel.
List prices are also set with expected pharmacy benefit manager rebates and manufacturer discounts already factored in. An insured patient's plan captures some of those discounts; a cash-pay patient at the Walgreens counter generally does not, which is why the sticker price and the negotiated net price diverge so widely for the same product.
Compounded semaglutide and tirzepatide sit in a separate regulatory pathway entirely: licensed compounding pharmacies prepare them from active pharmaceutical ingredients against an individual prescription. State pharmacy boards and, for 503B facilities, the FDA regulate that practice, but the resulting preparations are not FDA-approved as drugs. For a broader comparison of the telehealth options, see our best GLP-1 provider guide.
Tirzepatide Specifically: Zepbound, Mounjaro, and What Lilly Charges Directly
Tirzepatide deserves to be separated out from semaglutide here, because two things about it change the math at the counter. The first is that the same molecule is sold under two labels. Zepbound is tirzepatide approved for chronic weight management, and Mounjaro is tirzepatide approved for type 2 diabetes. Both are made by Eli Lilly. Which label your prescription is written against often decides whether your plan pays at all, because most commercial formularies treat the diabetes indication and the weight indication as separate coverage decisions.
The second is that the retail counter price and the prices Eli Lilly publishes for its own direct channel are different numbers quoted for different product forms, so they do not compare line for line. The retail cash figure cited elsewhere on this page is what a Walgreens register quotes. Lilly separately publishes prices for the Zepbound single-patient-use KwikPen, where a month is defined as 28 days. Checked on Lilly's Zepbound coverage and savings page on September 8, 2026:
| Route | What Lilly publishes for Zepbound |
|---|---|
| Commercial plan that covers the single-dose pen | As little as $25 for a 1-month, 2-month, or 3-month fill through the Zepbound Savings Program, for patients whose commercial drug insurance covers the single-dose pen. Terms and savings caps apply |
| Regular price, 2.5 mg KwikPen | $299 for a 1-month supply |
| Regular price, 5 mg KwikPen | $399 for a 1-month supply |
| Regular price, 7.5 mg KwikPen | $499 for a 1-month supply |
| Regular price, 10 mg, 12.5 mg, and 15 mg KwikPen | $699 for a 1-month supply |
| Purchase offer, 7.5 mg through 15 mg KwikPen | $449 for a 1-month supply, applied automatically on the first purchase. Staying on it requires completing each refill within 45 days of the previous delivery |
Look at the shape of that ladder. The regular price climbs as you titrate upward, and tirzepatide titration runs from 2.5 mg to 15 mg, so a patient who starts at the bottom and works up faces a bill that rises at roughly the point their dose settles. That is the opposite of what most people budget for. The $449 offer flattens the top of the ladder, but it is conditional rather than permanent: it turns on refill timing, so one late refill can put you back on the regular price. If you are paying for brand tirzepatide yourself, price the dose you expect to maintain rather than the dose you start on, and read the offer conditions before you count on the lower number. Our LillyDirect Zepbound pricing guide carries the full dose-by-dose breakdown.
Zepbound or Mounjaro on the prescription?
If you are being treated for weight and your plan denies Zepbound, a Mounjaro prescription is not a workaround. It is a different approved indication, and switching labels to chase coverage is a clinical decision for your prescriber, not a billing tactic. Ask instead about prior authorization, a formulary exception, or the manufacturer channel above.
Where Compounded Tirzepatide Fits
Walgreens fills brand-name and generic prescriptions, so compounded tirzepatide is not something you pick up at that counter. That route runs through a telehealth provider working with a compounding pharmacy, and it is priced on a different logic entirely: flat, rather than tiered by dose. Trimi charges $125 a month for compounded tirzepatide on the annual plan, which is a 12-month commitment, and that rate holds at every step of the titration rather than rising as you move up. The month-to-month rate is $235.
Compounded tirzepatide contains the active ingredient in Zepbound, prepared against an individual prescription by a state-licensed 503A pharmacy, and is not itself FDA-approved as a drug. The efficacy evidence people cite for this molecule comes from the brand product: SURMOUNT-1 studied tirzepatide over 72 weeks and reported average weight reduction of 20.9%. That trial was run on the FDA-approved medication, not on any compounded preparation, and no compounded version has been through a trial of its own. Whether compounded tirzepatide is appropriate for you is a decision for a licensed clinician, and Trimi's risk reversal is a 6-month money-back policy rather than a short-term out.
For a fuller side-by-side of the two tirzepatide routes, see Zepbound vs compounded tirzepatide, and for pricing across the whole category, tirzepatide cost in 2026.
Online visit with a licensed provider. No insurance required.
Bottom Line
Walgreens fills brand-name GLP-1 prescriptions reliably for patients with insurance coverage and manageable copays, and that is the route to pursue first: prior authorization, formulary appeal, the manufacturer savings card, and the manufacturer's own direct self-pay channel. Those are the paths to an FDA-approved product.
If none of them work out, compounded preparations through a telehealth provider are a separate conversation to have with a licensed clinician. Trimi's compounded semaglutide is $99/month and compounded tirzepatide is $125/month, flat cash-pay rates. See our GLP-1 telehealth pricing guide for how the providers in that category compare.
Frequently Asked Questions
How much does Wegovy cost at Walgreens?
Wegovy (semaglutide) at Walgreens costs approximately $1,200 to $1,400 per month without insurance. With insurance that covers GLP-1 medications, copays range from $25 to $500+ depending on your plan. Discount cards may reduce cash pricing to $900 to $1,100. Novo Nordisk also runs its own self-pay channel with separate eligibility rules.
How much does Zepbound cost at Walgreens?
Zepbound (tirzepatide) at Walgreens typically costs $900 to $1,100 per month without insurance. With insurance coverage, copays vary widely by plan, tier, and deductible status. Eli Lilly's LillyDirect self-pay program and the Zepbound Savings Card are the two manufacturer routes worth checking before you pay the counter price.
Does Walgreens price match GLP-1 medications?
Walgreens generally does not price match prescription medications from other pharmacies. Their pricing is based on their negotiated rates with manufacturers and PBMs. To find the lowest price on a brand-name GLP-1, compare across multiple pharmacies using a tool like GoodRx, and check the manufacturer's own direct-to-patient program separately.
Can I use a coupon for GLP-1 at Walgreens?
Yes, manufacturer coupons and discount cards (like GoodRx) can reduce GLP-1 prices at Walgreens. Manufacturer savings cards may offer significant first-month discounts for eligible patients, though most require commercial insurance and carry a benefit cap and an expiration date. Read the eligibility terms before you count on one.
Is Walgreens the most expensive pharmacy for GLP-1?
Walgreens pricing for brand-name GLP-1 is generally comparable to other major retail pharmacies like CVS and Rite Aid. The high cost is driven by brand-name manufacturer pricing, not pharmacy-specific markup. All retail pharmacies face the same fundamental pricing constraints for these medications.
Does Walgreens carry compounded semaglutide?
No, Walgreens is a retail pharmacy that fills brand-name and generic prescriptions. Compounded medications are produced and dispensed by specialized compounding pharmacies. To access compounded GLP-1 medications, patients work with telehealth providers like Trimi that partner directly with licensed compounding pharmacies.
What is different about getting a compounded GLP-1 through Trimi?
Trimi is a telehealth provider, not a retail pharmacy. A licensed provider evaluates you online, and if appropriate, a 503A compounding pharmacy prepares the medication against your individual prescription. Trimi's rate is a flat $99/month for compounded semaglutide and $125/month for compounded tirzepatide, cash-pay, with the consultation and shipping included. Compounded preparations are not FDA-approved as drugs and have not been evaluated by FDA for safety, effectiveness, or manufacturing quality.
Sources & References
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication. Trimi competes in the GLP-1 space, this pricing analysis aims to be accurate, but readers should be aware of our perspective.